<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250429065518N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-05-22</date_registration>
      <primary_sponsor>Office of the Research Deputy, School of Dentistry, Tehran University of medical Sciences</primary_sponsor>
      <public_title>Comparison of Analgesic Effect of Inferior Alveolar Nerve Block and Lidocaine Infiltration in Posterior Mandibular Implant Placement: A Split-Mouth Randomized Clinical Trial</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of Inferior Alveolar Nerve Block Versus Local Infiltration with 2% Lidocaine for Pain Management in Posterior Mandible Implant Surgery: A Randomized Double-Blind Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-12-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/83192</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: randomization conducted using block randomization (blocks of 4), generated by Excel software, Blinding description: In this process, the patients and the evaluator responsible for assessing the pain are blinded to the contents of the envelopes. The statistician responsible for the randomization process and the surgeon performing the procedure could not be blinded. However, the patient and the evaluator responsible for assessing the patient’s pain are blinded and do not know which injection is performed on each side.</study_design>
      <phase>N/A</phase>
      <hc_freetext>implant placement in the posterior region of Mandible.</hc_freetext>
      <i_freetext>Intervention 1: The randomly selected hemi-mandible is going to be anesthetized using the IANB technique. Intervention 2: Control group: The randomly selected hemi-mandible is going to be anesthetized using the infiltration technique.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Comparison of Analgesic Effect of Inferior Alveolar Nerve Block and Lidocaine Infiltration in Posterior Mandibular Implant Placement: A Split-Mouth Randomized Clinical Trial 
The following data/documents will be shared:

De-identified Individual Participant Data (IPD): Includes demographic information, procedural data, pain scores (VAS), and outcomes related to anesthesia techniques.
Study Protocol Document: Encompasses the experimental design, ethical approvals, and statistical analysis methods.
Thesis and Article Files: Includes the complete thesis and the final published article documenting the study.
Consent Forms: Translated versions of patient information sheets and consent forms, upon qualified request.

When:
The data/documents will be available 6 months after the publication of the main study results.
The availability period will last for an indefinite period

To whom:
Researchers who are affiliated with recognized academic institutions.
Healthcare policymakers and practitioners working in the field.
Industry researchers, upon providing justified scientific use cases.

Conditions:
To access the shared data/documents, applicants must:

Submit a research proposal outlining intended analyses (e.g., secondary analyses, meta-analyses, validation studies).
Agree to use the data ethically and responsibly, adhering to participant confidentiality standards.
Allow publications to include only aggregate-level data, ensuring non-identifiable results.
All requests will be reviewed by the research team and ethics committee, granting access based on scientific merit.

Where to obtain:
Applicants can request data/documents by contacting:

Contact Person: Dr. Nima Dehghani – Corresponding Author
Email: nimadt2002@gmail.com
Postal Address: Department of Oral and Maxillofacial Surgery, Tehran University of Medical Sciences, School of Dentistry, Postal Code: 1439955991
Phone: +9821-22273471
Fax: +9821-88497390

How to obtain:
Submit a formal request including:
Research Proposal
Intended Data Use
Administrative and ethical review conducted by:
Research team and ethics committee
Sign a Data Use Agreement confirming compliance with ethical guidelines.
The review process typically takes 2–4 weeks after receiving all required documents.

Comments:
All shared data will be fully anonymized to protect participant confidentiality. Certain datasets may be restricted due to consent limitations or local regulations.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nima Dehghani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 121, 9th boostan st., Pasdaran alley</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1439955991</zip>
        <telephone>+98 21 2279 7274</telephone>
        <email>nimadt2002@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nima Dehghani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 121, 9th boostan st., Pasdaran alley</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1439955991</zip>
        <telephone>+98 21 2279 7274</telephone>
        <email>nimadt2002@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Eligible patients were aged 18 or older.
Systemically healthy
Candidates for bilateral implant surgery in the first or second molar region
It was essential that the alveolar ridge in the surgical site had fully healed and reconstructed adequately.</inclusion_criteria>
      <agemin>28 years</agemin>
      <agemax>69 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with systemic conditions contraindicating surgery or an allergy to local anesthetics.
Pregnant individuals
Heavy smokers
Individuals suffering from untreated periodontal conditions.
Patients who had taken medications affecting pain perception (such as analgesics, antidepressants, or sedatives) within 48 hours prior to surgery.
Individuals with active pathological conditions at the injection site.
Cases requiring immediate implant placement.
Cases needing bone grafting.
Individuals suffering from extreme dental anxiety or phobia, or neurological disorders.
Individuals who were familiar with the distinct injection techniques (e.g., dental professionals).</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z96.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Presence of tooth-root and mandibular implants</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The randomly selected hemi-mandible is going to be anesthetized using the IANB technique.</i_keyword>
      <i_keyword>Control group: The randomly selected hemi-mandible is going to be anesthetized using the infiltration technique.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The primary outcome variable is pain intensity during surgery and 24 hours after surgery. Pain intensity was assessed using the Visual Analogue Scale (VAS). Timepoint: Pain intensity will be measured during the surgery and at 24 hours post-surgery. Method of measurement: Pain intensity will be measured using the Visual Analogue Scale (VAS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Office of the Research Deputy, School of Dentistry, Tehran University of medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-07-25</approval_date>
        <contact_name>Ethics Committee at Tehran University of Medical Science</contact_name>
        <contact_address>Secretariat of the Ethics Committee in Biomedical Research, Tehran University - Keshavarz Boulevard - Qods Street Intersection - Central Building of Tehran University of Medical Sciences - 6th Floor - Room 604 Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
